What if we could predict early in drug development which antibiotics bacteria are most likely to become resistant to? In a review published in Nature Reviews Microbiology, researchers from the HUN-REN Biological Research Centre, Szeged (HUN-REN BRC Szeged) and the Hungarian Centre of Excellence for Molecular Medicine (HCEMM) in Szeged propose a five-step decision-making framework that could help identify resistance risks early, refine promising drug candidates and prevent costly failures.
Predicting Antibiotic Resistance Early in Drug Development to Enhance Treatment Efficacy
Researchers from HUN-REN BRC Szeged and HCEMM propose a framework to predict antibiotic resistance during drug development. This approach aims to refine drug candidates and prevent failures in treatment. The implications for Iran include potential advancements in healthcare and pharmaceutical development.
👥 Key Players
📰 What Happened
Researchers from Hungary have proposed a new framework to predict antibiotic resistance during the early stages of drug development. This aims to improve the efficacy of treatments and reduce the risk of costly failures in the pharmaceutical industry.
- The proposed framework includes a five-step decision-making process.
- The research was published in the prestigious journal Nature Reviews Microbiology.
💡 Why It Matters
📚 Background
Antibiotic resistance is a major public health challenge worldwide, leading to increased morbidity and mortality. Understanding and predicting resistance patterns is vital for developing effective treatments.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%